Clinical trial suggests combination therapy is best for low-grade brain tumors
3/13/2015
New clinical-trial findings provide further evidence that combining chemotherapy with radiation therapy is the best treatment for people with a low-grade form of brain cancer.
Study explains control of cell metabolism in breast cancer
3/13/2015
Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have discovered a mechanism that explains why some breast cancer tumors respond to specific chemotherapies and others do...
Merck, known as MSD outside the United States and Canada, has announced that the company's anti-PD-1 therapy, pembrolizumab, which is marketed in the U.S.
TSRI scientists show that proteins critical in day-night cycles also protect cells from mutations
3/12/2015
A good night's sleep does more than prevent yawning. New research from The Scripps Research Institute (TSRI) shows that two proteins critical for maintaining healthy day-night cycles also protect...
The delays and rejections associated with the current NICE appraisal system are both delaying and preventing patients from accessing new cancer medicines in the UK, where survival rates for cancer...
Lateral thinking about chromosome linking
3/12/2015
Scientists led by a group at the University of Dundee have made a significant discovery about how our cells properly inherit their genetic information.
Hospital readmissions following severe sepsis often preventable
3/12/2015
In an analysis of about 2,600 hospitalizations for severe sepsis, readmissions within 90 days were common, and approximately 40 percent occurred for diagnoses that could potentially be prevented or...
Johns Hopkins researchers engineer custom blood cells
3/12/2015
Step toward new treatment for patients with sickle cell diseaseThese are human blood cells grown in the lab from genetically edited stem cells.
Hippo 'crosstalk' may be vital to tumor suppression
3/12/2015
MD Anderson study reveals new understanding of key cell-signaling pathwayThink of a waterfall, and you might see why cell-signaling pathways are important to cancer research.
Ledipasvir plus sofosbuvir: Hint of added benefit in certain patients
3/12/2015
Better virologic response in genotype 1 chronic hepatitis C / no data or no suitable data for further patient groupsThe drug combination of ledipasvir and sofosbuvir (trade name Harvoni) has been...